Doxycycline hyclate tablets recalled after stability testing failed dissolution specifications
Acella Pharmaceuticals is recalling 4,680 five-hundred-count bottles of Doxycycline Hyclate Tablets USP 100 mg after stability testing found the lot did not meet dissolution specifications.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: Scored 2 as a specification failure: the record states only that dissolution specifications were not met, without describing a health consequence or reporting injury.
Plain-English summary
Doxycycline Hyclate Tablets, USP 100 mg, in 500-count bottles, distributed by Acella Pharmaceuticals of Alpharetta, Georgia, are being recalled for failed dissolution specifications. Stability testing found that the lot did not meet those specifications.
The recall covers 4,680 bottles from lot P24ZLK1, expiring 31 May 2027, carrying NDC 42192-501-05. The product was distributed nationwide in the United States. The FDA has classified the recall as Class II.
The enforcement record states the dissolution failure without describing a health consequence, and reports no injuries.
Doxycycline is a prescription antibiotic, so patients holding the affected lot should contact their pharmacy or prescriber about a replacement rather than stopping treatment on their own.
The recalled product
- Product
- DOXYCYCLINE (DOXYCYCLINE HYCLATE)
- Brand
- DOXYCYCLINE
- Manufacturer
- Acella Pharmaceuticals, LLC
- Category
- Drug — Antibiotic
- Hazard
- failed-dissolution
- out-of-specification
- stability-failure
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: P24ZLK1
- Exp 5/31/2027
UPCs (1)
- 0342192501058
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · DOXYCYCLINE
- ModerateDoxycycline Capsules Recalled Due to Temperature Storage Deviation
FDA (Drugs) · 2024-01-03
- ModerateDoxycycline Capsules Recalled for Temperature Control Deviation
FDA (Drugs) · 2022-06-15
Same category
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- ModerateQuality Choice Earwax Removal Kit Carbamide Peroxide Subpotent Drug Recall
FDA (Drugs) · 2026-07-22
- ModerateFamily Wellness Carbamide Peroxide Earwax Removal Kit Subpotent Drug
FDA (Drugs) · 2026-07-22
- ModerateLeader Carbamide Peroxide Earwax Removal Kit Recalled for Subpotency
FDA (Drugs) · 2026-07-22
- ModerateNystatin Cream Recall Due to Low Potency Test Results
FDA (Drugs) · 2026-07-22